Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08FYH
|
||||
Former ID |
DIB007746
|
||||
Drug Name |
PF-04776548
|
||||
Synonyms |
PF-04776548 (oral, HIV infection)
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 1 | [522912] | ||
Company |
Pfizer Inc
|
||||
Target and Pathway | |||||
Target(s) | HIV protease | Target Info | Modulator | [522912] | |
References | |||||
Ref 522912 | ClinicalTrials.gov (NCT01045317) A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body. U.S. National Institutes of Health. | ||||
Ref 522912 | ClinicalTrials.gov (NCT01045317) A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.